Mirae Asset Global Etfs Holdings Ltd. Oric Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 26,658 shares of ORIC stock, worth $303,101. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,658
Previous 40,201
33.69%
Holding current value
$303,101
Previous $224,000
20.54%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ORIC
# of Institutions
146Shares Held
91.8MCall Options Held
1.03MPut Options Held
10.1K-
Nextech Invest, Ltd. Zurich, V87.16MShares$81.4 Million13.76% of portfolio
-
Vr Adviser, LLC New York, NY6.6MShares$75 Million13.26% of portfolio
-
Viking Global Investors LP6.57MShares$74.7 Million0.21% of portfolio
-
Nextech Invest Ag5.29MShares$60.1 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$54.9 Million0.0% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $450M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...